Vonocab Trio Tablet is a fixed-dose combination of Vonoprazan 20 mg, Amoxicillin 1000 mg, and Clarithromycin 500 mg, specially formulated for the eradication of Helicobacter pylori (H. pylori) infection. This combination therapy is widely used in patients with peptic ulcer disease, chronic gastritis, and other acid-related gastrointestinal disorders associated with H. pylori infection. By combining a potent acid suppressant with two broad-spectrum antibiotics, Vonocab Trio offers a comprehensive and effective treatment approach.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Vonoprazan: 20 mg

• Amoxicillin: 1000 mg

• Clarithromycin: 500 mg

• Dosage form: Tablet

• Route of administration: Oral

Mechanism of Action

Vonocab Trio works through a synergistic mechanism. Vonoprazan, a potassium-competitive acid blocker (P-CAB), rapidly and strongly suppresses gastric acid secretion by inhibiting the H⁺/K⁺-ATPase enzyme in the stomach. Unlike conventional proton pump inhibitors, it provides consistent acid suppression without requiring acid activation.

Amoxicillin is a penicillin-class antibiotic that disrupts bacterial cell wall synthesis, while Clarithromycin, a macrolide antibiotic, inhibits bacterial protein synthesis. Together, these antibiotics effectively eliminate H. pylori bacteria. The strong acid suppression provided by Vonoprazan enhances antibiotic stability and activity, improving eradication rates.

Indications

Vonocab Trio Tablet is indicated for:

• Eradication of Helicobacter pylori infection

• Treatment of H. pylori–associated gastric and duodenal ulcers

• Chronic gastritis linked to H. pylori

• Prevention of ulcer recurrence after successful eradication

• Part of combination therapy in acid-related gastrointestinal disorders

Dosage and Administration

The dosage and duration of Vonocab Trio Tablet should be prescribed by a healthcare professional. It is typically administered as part of a structured eradication regimen for a specified number of days. Tablets should be taken orally with water and can be taken with or without food. Patients are advised to complete the full course of therapy to ensure successful eradication and reduce the risk of antibiotic resistance.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Benefits and Key Features

• High H. pylori eradication success rates

• Rapid and sustained acid suppression

• Enhanced antibiotic effectiveness due to stable gastric pH

• Convenient fixed-dose combination

• Reduces pill burden and improves patient compliance

• Effective in patients with previous treatment failure using standard PPI-based regimens

Safety and Precautions

Vonocab Trio Tablet is generally well tolerated when used as directed. Possible side effects include nausea, diarrhea, abdominal pain, taste disturbance, headache, or allergic reactions. Patients with known hypersensitivity to penicillins, macrolides, or any component of the formulation should avoid this medication. Caution is advised in patients with liver impairment or a history of antibiotic-associated colitis. Use during pregnancy and breastfeeding should only occur under medical supervision.

Storage

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children.

Vonocab Trio Tablet from SK Pharma offers an advanced and reliable solution for H. pylori eradication, combining modern acid suppression with proven antibiotic therapy to support effective healing and long-term gastrointestinal health.